NuLife Sciences Inc. Stock Price - NULF

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Nulife Sciences Inc. (QB) NULF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.0385 +6.53% 0.6285 0.6285 0.6285 0.6285 0.59 16:41:22
Bid Price Ask Price Spread Spread % News
0.15 0.64 0.49 76.56% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1 650 $ 0.6285 $ 408.525 6.37k - - -
Last Trade Time Type Quantity Stock Price Currency
12:56:34 650 $0.63 USD

Nulife Sciences Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 19.54M 31.09M $ -559.27k - -34.93 6.99M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1000 0.00% $ - 0.00% - -

more financials information »

Nulife Sciences Inc. (QB) News

Historical NULF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.640.640.590.000006k1k-0.0115-1.80%
1 Month0.660.670.530.0000011k3k-0.0315-4.77%
3 Months0.25651.500.25650.0000087k14k0.372145.03%
6 Months0.25651.500.25650.0000087k14k0.372145.03%
1 Year0.25651.500.25650.0000087k14k0.372145.03%
3 Years0.25651.500.25650.0000087k14k0.372145.03%
5 Years0.25651.500.25650.0000087k14k0.372145.03%

Nulife Sciences Inc. (QB) Description

NuLife Sciences is a biomedical company focused on advancing human organ transplant technology and medical research. NuLife has a patent protected unique proprietary method ("NuLife Technique") that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs. With a massive need and market for organ transplants, and over 123K candidates waiting for an organ in the U.S. alone, NuLife's versatile technique is suitable for a variety of clinical indications. The Company has completed discovery phase for its technique, and is now entering a Preclinical phase involving animal experiments on its pathway to commercialization. For additional information please visit:

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.